the aid library

Сиволап Ю.П. (2014) CC

Злоупотребление алкоголем и алкоголизм относятся к ведущим причинам ухудшения здоровья и повышения смертности населения. Чрезмерное употребление алкоголя служи... more

Download (111)

View PDF (173)

Глобальная стратегия сокращения вредного употребления алкоголя

World Health Organization WHO (2010) C_WHO

По оценкам, от вредного употребления алкоголя ежегодно умирают 2,5 миллиона человек, значительную долю из которых составляет молодежь. Употребление алкоголя являе�... more

Download (107)

View PDF (159)

Реагирование на неинфекционные заболевания во время пандемии COVID-19 и после ее завершения

Всемирная Организация Здравоохранения ВОЗ (2020) C_WHO

В настоящем документе представлен первоначальный обзор поступающей информации (по состоянию на 2 июля 2020 г.) о взаимосвязи между COVID-19, НИЗ и факторами риска НИЗ. Ре... more

Download (105)

View PDF (154)

Медикосоциальные аспекты реабилитации больных с пограничными психическими расстройствами

Карелина Д. Д., Кром И. Л., Барыльник Ю. Б. Саратовский научно-медицинский журнал. (2011) C1

Рассматриваются факторы, оказывающие влияние на процесс медикосоциальной реабилитации больных с пограничными психическими расстройствами в современном социуме... more

Download (302)

View PDF (531)

Влияние пандемии COVID-19 на планирование семьи и борьбу с гендерным насилием, калечащими операциями на женских половых органах и детскими браками

UNFPA, with contributions from Avenir Health, Johns Hopkins University (USA) and Victoria University (Australia) UNFPA (2020) C1

Фонд ООН в области народонаселения (ЮНФПА) стремится достичь трех изменяющих мир результатов к 2030 году - крайнему сроку достижения Целей в Области Устойчивого Раз... more

Download (271)

View PDF (255)

HEARTS. Protocoles thérapeutiques basés sur des données factuelles

Organisation Mondiale de la Santé OMS, et al. (2018) C_WHO

Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires

Download (320)

View PDF (321)

HEARTS Paquete técnico para el manejo de las enfermedades cardiovasculares en la atencion primaria de salud. Evidencia: Protocolos de tratamiento clinico basados en la evidencia

Pan American Health Organization (PAHO) (2018) C_WHO

Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de los ministerios de salud cuyo trabajo influye sobre la prestación de servicios de salud a nivel prima... more

External Link

South African cardiovascular risk stratification guideline for non-cardiac surgery

Alphonsus, C.; Naidoo, N.; Motshabi, P. et al. South African Medical Journal (2021) CC

The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa. The guidelines were developed by updating the Canadian ...Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Non-cardiac Surgery, with a search of literature from African countries and recent publications. The updated proposed guidelines were then evaluated in a Delphi consensus process by SA anaesthesia and vascular surgical experts. The recommendations in these guidelines are: 1. We suggest that elective non-cardiac surgical patients who are 45 years and older with either a history of coronary artery disease, congestive cardiac failure, stroke or transient ischaemic attack, or vascular surgical patients 18 years or older with peripheral vascular disease require further preoperative risk stratification as their predicted 30-day major adverse cardiac event (MACE) risk exceeds 5% (conditional recommendation: moderate-quality evidence). 2. We do not recommend routine non-invasive testing for cardiovascular risk stratification prior to elective non-cardiac surgery in adults (strong recommendation: low-to-moderate-quality evidence). 3. We recommend that elective non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease should have preoperative natriuretic peptide (NP) screening (strong recommendation: high-quality evidence). 4. We recommend daily postoperative troponin measurements for 48 - 72 hours for non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease, i.e. (i) a baseline risk >5% for MACE 30 days after elective surgery (if no preoperative NP screening), or (ii) an elevated B-type natriuretic peptide (BNP)/N-terminal-prohormone B-type natriuretic peptide (NT-proBNP) measurement before elective surgery (defined as BNP >99 pg/mL or a NT-proBNP >300 pg/mL) (conditional recommendation: moderate-quality evidence). Additional recommendations are given for the management of myocardial injury after non-cardiac surgery (MINS) and medications for comorbidities. more

Download (250)

View PDF (310)

Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans

Ojji, D.B.; et al. (2019) C1

N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113

Download (1498)

View PDF (2836)

Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended

World Health Organization WHO (2007) C_WHO

This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.

Download (1512)

View PDF (2210)

Hypertension in developing countries

M Mohsen Ibrahim, Albertino Damasceno The Lancet (2012)

Lancet 2012; 380: 611–19 Series: Hypertension 3

Download (452)

View PDF (494)

HEARTS Paquete técnico para el manejo de las enfermedades cardiovasculares en la atención primaria de salud. Guía de implementación

Pan American Health Organization (PAHO) (2019) C_WHO

Download (356)

View PDF (387)

HEARTS Paquete técnico para el manejo de las enfermedades cardiovasculares en la atención primaria de salud. Acceso a medicamentos y tecnologías esenciales

Pan American Health Organization (PAHO) (2018) C_WHO

Download (310)

View PDF (367)

Hypertension et COVID-19

World Health Organization WHO (2021) C_WHO

Note d’information scientifique, 17 juin 2021

Download (1478)

View PDF (2821)

Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk
recommended

World Health Organization WHO (2007) C_WHO

These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people

Download (225)

View PDF (300)

HEARTS. Technical package for cardiovascular disease management in primary health care.

World Health Organization WHO (2016) C_WHO

The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul... more

Download (294)

View PDF (326)

Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020

Pan American Health Organisation PAHO (2020) C_WHO

Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managing people with these co-morbidities who acquire COV... more

Download (458)

View PDF (525)

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

European Society of Cardiology (2020) C1

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels; Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19; Patien... more

Download (121)

View PDF (114)

Guidelines for Management of ST-Elevated Myocardial Infarction

Directorate General of Health Services Ministry of Health & Family Welfare Government of India (2022) CC

Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi... more

Download (116)

View PDF (121)

National User Guide on the Prevention and Treatment of Hypertension in Adults at the PHC Level 2021

Health Department: Republic of South Africa (2021) CC

Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o... more

Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk recommended

Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk recommended

Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended

Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk
recommended